Harrison H. Tran

A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteers☆

L. Leggio, Kimberly Goodyear, R. Swift, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Administration of the metabotropic glutamate receptor subtype 5 allosteric modulator GET 73 with alcohol: A translational study in rats and humans

L. Leggio, Kimberly Goodyear, G. Colombo, 2018, Journal of psychopharmacology.

Dataset for Phase I randomized clinical trial for safety and tolerability of GET 73 in single and repeated ascending doses including preliminary pharmacokinetic parameters

L. Leggio, Kimberly Goodyear, R. Swift, 2017, Data in brief.